REFERENCES
- Goldstein H., Lue T. F., Padma-Nathan H., Rosen R. C., Steers W. D., Wicker P. A. Oral Sildenafil in the Treatment of Erectile Dysfunction. N. Engl. J. Med. 1998; 338: 1397–1404
- Stief C. G., Uckert S., Becker A. J., Truss M. C., Jonas U. The Effect of the Specific Phosphodiesterase (PDE) Inhibitors on Human and Rabbit Cavernous Tissue in vitro and in vivo. J. Urol. 1998; 159: 1390–1393
- Zusman R. M., Morales A., Glasser D. B., Osterloh I. H. Overall Cardiovascular Profile of Sildenafil Citrate. Am. J. Cardiol. 1999; 83: 35C–44C
- Krenzelok E. P. Sildenafil: Clinical Toxicology Profile. J. Toxicol. Clin. Toxicol. 2000; 38: 645–651
- Kloner R. A., Zusman R. M. Cardiovascular Effects of Sildenafil Citrate and Recommendations for Its Use. Am. J. Cardiol. 1999; 84: 11N–17N